ENDRA Life Sciences Inc.
NDRA- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001681682
No open-market purchases or sales by ENDRA Life Sciences Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $819.0K in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in ENDRA Life Sciences Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +4 vs. Q1 2024
- Shares held
- 830.1K
- +566.1K (+214.5%) vs. Q1 2024
- Total value
- $80.6K
- −$72.4K (−47.3%) vs. Q1 2024
- New holders
- 9
- 6 more added
- Sold out
- 5
- 1 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NDRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $819.0K |
| Q1 2026 | 8 | $416.8K |
| Q4 2025 | 7 | $325.4K |
| Q3 2025 | 5 | $70.4K |
| Q2 2025 | 3 | $16.6K |
| Q1 2025 | 2 | $4.65K |
| Q4 2024 | 4 | $720 |
| Q3 2024 | 11 | $32.9K |
| Q2 2024 | 17 | $80.6K |
| Q1 2024 | 13 | $153.0K |
| Q4 2023 | 11 | $277.3K |
| Q3 2023 | 10 | $156.3K |
| Q2 2023 | 12 | $267.5K |
| Q1 2023 | 14 | $384.7K |
| Q4 2022 | 14 | $569.5K |
| Q3 2022 | 16 | $1.08M |
| Q2 2022 | 20 | $1.02M |
| Q1 2022 | 20 | $1.54M |
| Q4 2021 | 20 | $3.06M |
| Q3 2021 | 20 | $6.06M |
| Q2 2021 | 23 | $7.75M |
| Q1 2021 | 22 | $8.35M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding ENDRA Life Sciences Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 69 | $7 | 0.00% | +69 | New |
| Federation des caisses Desjardins du Quebec | 1,000 | $97 | 0.00% | +1,000 | New |
| Morgan Stanley | 10,332 | $1.00K | 0.00% | +10,000+3,012.0% | Added |
| Marex Group plc | 12,800 | $1.24K | 0.00% | +12,800 | New |
| XTX Topco Ltd | 14,853 | $1.44K | 0.00% | +4,095+38.1% | Added |
| Brevan Howard Capital Management LP | 15,991 | $1.55K | 0.00% | +15,991 | New |
| Sassicaia Capital Advisers LLC | 16,000 | $1.55K | 0.01% | +16,000 | New |
| StoneX Group Inc. | 16,766 | $1.63K | 0.00% | +16,766 | New |
| Kestra Advisory Services, LLC | 22,500 | $2.19K | 0.00% | +22,500 | New |
| GWM Advisors LLC | 29,985 | $2.91K | 0.00% | −952−3.1% | Reduced |
| Tower Research Capital LLC (TRC) | 34,020 | $3.30K | 0.00% | +25,364+293.0% | Added |
| Susquehanna International Group, LLP | 37,838 | $3.67K | 0.00% | +37,838 | New |
| Vanguard Group Inc | 39,812 | $3.87K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 55,453 | $5.38K | 0.00% | +55,313+39,509.3% | Added |
| Geode Capital Management, LLC | 76,171 | $7.40K | 0.00% | +21,929+40.4% | Added |
| Jane Street Group, LLC | 116,914 | $11.4K | 0.00% | +80,799+223.7% | Added |
| HRT Financial LP | 329,571 | $32.0K | 0.00% | +329,571 | New |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −47,914−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −34,644−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −329−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |